Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprex for preventing left ventricular mass growth in renal insufficiency
NCT00364260Phase 3Completed
- Sponsor
- Janssen Ortho
- Start
- Dec 1997
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Janssen Ortho. Started Dec 1997; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00364260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364260.